HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marie-Paule Lefranc Selected Research

Colorectal Neoplasms (Colorectal Cancer)

9/2017Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marie-Paule Lefranc Research Topics

Disease

11Lymphoma (Lymphomas)
01/2019 - 01/2003
10Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 01/2003
9Leukemia
01/2009 - 01/2003
7Infections
11/2020 - 08/2005
7Autoimmune Diseases (Autoimmune Disease)
01/2009 - 01/2003
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2021 - 05/2012
5Communicable Diseases (Infectious Diseases)
04/2014 - 01/2005
3Neoplasms (Cancer)
09/2017 - 06/2006
3Anthrax
12/2008 - 08/2005
1HIV Infections (HIV Infection)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
09/2017
1Residual Neoplasm
10/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2016
1Disease Progression
11/2014
1Virus Diseases (Viral Diseases)
01/2013
1Human Influenza (Influenza)
01/2013
1Disease Resistance
04/2012
1Alzheimer Disease (Alzheimer's Disease)
11/2010
1Graves Disease (Basedow Disease)
02/2007
1Hyperthyroidism
02/2007
1Thyroid Diseases (Thyroid Disease)
06/2002

Drug/Important Bio-Agent (IBA)

12AntibodiesIBA
01/2019 - 01/2005
7Immunoglobulins (Immunoglobulin)IBA
11/2021 - 06/2006
3AntigensIBA
01/2019 - 08/2007
2VaccinesIBA
11/2020 - 08/2015
2Monoclonal AntibodiesIBA
04/2014 - 12/2007
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2013 - 06/2006
1Aluminum Hydroxide (Algeldrate)FDA Link
11/2020
1Complementarity Determining Regions (Complementarity Determining Region)IBA
01/2019
1EpitopesIBA
01/2019
1big gastrinIBA
09/2017
1Humanized Monoclonal AntibodiesIBA
09/2017
1CateninsIBA
09/2017
1Peptides (Polypeptides)IBA
09/2017
1Immunoglobulin M (IgM)IBA
01/2013
1Immunoglobulin D (IgD)IBA
01/2013
1Poly I-CIBA
01/2012
1Immunoglobulin FragmentsIBA
12/2008
1Cetuximab (Erbitux)FDA Link
12/2007
1Rituximab (Mabthera)FDA Link
12/2007
1Bevacizumab (Avastin)FDA Link
12/2007
1Alemtuzumab (Campath)FDA Link
12/2007
1Immunoglobulin Variable RegionIBA
12/2007
1Trastuzumab (Herceptin)FDA Link
12/2007
1Thyrotropin Receptors (Thyrotropin Receptor)IBA
02/2007
1Anti-Bacterial Agents (Antibiotics)IBA
08/2005
1Iodide Peroxidase (Deiodinase)IBA
06/2002
1AutoantibodiesIBA
06/2002

Therapy/Procedure

9Immunotherapy
01/2009 - 01/2003
4Therapeutics
01/2018 - 08/2005
1Drug Therapy (Chemotherapy)
09/2017
1Stem Cell Transplantation
01/2012